Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ISM1 antisense RNA 1 (ISM1-AS1) is a long non-coding RNA gene identified in the human genome. Long non-coding RNAs are RNA molecules greater than 200 nucleotides in length that are not translated into protein, and many play regulatory roles at the transcriptional or post-transcriptional level[4][6][7]. However, as of this assessment, the specific biological roles, disease associations, or molecular mechanisms of ISM1-AS1 have not been established in the published literature or curated databases. There is no evidence it acts as a receptor, enzyme, transporter, or similar canonical drug target[7]. If more detailed or functional information about ISM1-AS1 emerges in the future, it may provide the basis for a more complete classification. For now, it is best described as a lncRNA gene with unknown function and no current role as a therapeutic target.
None described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ISM1 antisense RNA 1 (ISM1-AS1).